Stay updated on Bumetanide Oral Liquid in ASD Children Clinical Trial
Sign up to get notified when there's something new on the Bumetanide Oral Liquid in ASD Children Clinical Trial page.

Latest updates to the Bumetanide Oral Liquid in ASD Children Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedEditorial updates clarify that PubMed publications are automatically populated for the study page, and update the page revision label to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check28 days agoChange DetectedRemoved the government funding lapse notice about potential updates and NIH operations from the page.SummaryDifference0.2%

- Check49 days agoChange DetectedThe new screenshot shows minor visual/layout adjustments with no changes to core content such as the study title, conditions, design, outcomes, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedRemoved a help/lay summary link section: 'Helpful Links Provided by Servier (Institut de Recherches Internationales Servier) Lay summary'.SummaryDifference0.4%

- Check71 days agoChange DetectedUpdated operating-status notice and version to v3.2.0, replacing v3.1.0; core content remains the same aside from the new funding/status notice.SummaryDifference3%

- Check78 days agoChange DetectedAdded a new version tag (v3.1.0) and removed four drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.SummaryDifference0.3%

Stay in the know with updates to Bumetanide Oral Liquid in ASD Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bumetanide Oral Liquid in ASD Children Clinical Trial page.